Literature DB >> 22128286

c-MET: an exciting new target for anticancer therapy.

Johann S de Bono1, Timothy A Yap.   

Abstract

Entities:  

Year:  2011        PMID： 22128286      PMCID： PMC3225019          DOI： 10.1177/1758834011423402

Source DB:  PubMed          Journal:  Ther Adv Med Oncol        ISSN： 1758-8340            Impact factor:   8.168


× No keyword cloud information.
  18 in total

Review 1.  Scatter-factor and semaphorin receptors: cell signalling for invasive growth.

Authors:  Livio Trusolino; Paolo M Comoglio
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

Review 2.  Met, metastasis, motility and more.

Authors:  Carmen Birchmeier; Walter Birchmeier; Ermanno Gherardi; George F Vande Woude
Journal:  Nat Rev Mol Cell Biol       Date:  2003-12       Impact factor: 94.444

Review 3.  Targeting the HGF/c-Met axis: state of play.

Authors:  Timothy A Yap; Johann S de Bono
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

Review 4.  Envisioning the future of early anticancer drug development.

Authors:  Timothy A Yap; Shahneen K Sandhu; Paul Workman; Johann S de Bono
Journal:  Nat Rev Cancer       Date:  2010-06-10       Impact factor: 60.716

Review 5.  Invasive growth: a MET-driven genetic programme for cancer and stem cells.

Authors:  Carla Boccaccio; Paolo M Comoglio
Journal:  Nat Rev Cancer       Date:  2006-08       Impact factor: 60.716

6.  Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud.

Authors:  F Bladt; D Riethmacher; S Isenmann; A Aguzzi; C Birchmeier
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

7.  Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity.

Authors:  Annalisa Petrelli; Paola Circosta; Luisa Granziero; Massimiliano Mazzone; Alberto Pisacane; Silvia Fenoglio; Paolo M Comoglio; Silvia Giordano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-17       Impact factor: 11.205

8.  Scatter factor/hepatocyte growth factor is essential for liver development.

Authors:  C Schmidt; F Bladt; S Goedecke; V Brinkmann; W Zschiesche; M Sharpe; E Gherardi; C Birchmeier
Journal:  Nature       Date:  1995-02-23       Impact factor: 49.962

Review 9.  Novel therapeutic inhibitors of the c-Met signaling pathway in cancer.

Authors:  Joseph Paul Eder; George F Vande Woude; Scott A Boerner; Patricia M LoRusso
Journal:  Clin Cancer Res       Date:  2009-03-24       Impact factor: 12.531

10.  MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.

Authors:  Michèle Beau-Faller; Anne-Marie Ruppert; Anne-Claire Voegeli; Agnès Neuville; Nicolas Meyer; Eric Guerin; Michèle Legrain; Bertrand Mennecier; Jean-Marie Wihlm; Gilbert Massard; Elisabeth Quoix; Pierre Oudet; Marie P Gaub
Journal:  J Thorac Oncol       Date:  2008-04       Impact factor: 15.609
View more
  4 in total

1.  Isolation and Characterization of Human Lung Lymphatic Endothelial Cells.

Authors:  Bruno Lorusso; Angela Falco; Denise Madeddu; Caterina Frati; Stefano Cavalli; Gallia Graiani; Andrea Gervasi; Laura Rinaldi; Costanza Lagrasta; Davide Maselli; Letizia Gnetti; Enrico M Silini; Eugenio Quaini; Luca Ampollini; Paolo Carbognani; Federico Quaini
Journal:  Biomed Res Int       Date:  2015-06-07       Impact factor: 3.411

Review 2.  Role of cMET in the development and progression of colorectal cancer.

Authors:  Juan Carlos Samamé Pérez-Vargas; Pamela Biondani; Claudia Maggi; Manuela Gariboldi; Annunziata Gloghini; Alessandro Inno; Chiara Costanza Volpi; Ambra Vittoria Gualeni; Maria di Bartolomeo; Filippo de Braud; Alessandra Castano; Ilaria Bossi; Filippo Pietrantonio
Journal:  Int J Mol Sci       Date:  2013-09-03       Impact factor: 5.923

Review 3.  Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis.

Authors:  Taha Azad; Reza Rezaei; Abera Surendran; Ragunath Singaravelu; Stephen Boulton; Jaahnavi Dave; John C Bell; Carolina S Ilkow
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

Review 4.  MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review.

Authors:  Yiting Dong; Jiachen Xu; Boyang Sun; Jie Wang; Zhijie Wang
Journal:  Mol Diagn Ther       Date:  2022-03-10       Impact factor: 4.074
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.